Powering the future diagnosis, monitoring and treatment of respiratory illness

  • 24/7 Monitoring Image

    24/7 Monitoring

    PneumoWave captures data continuously, allowing real-time detection of adverse events

  • AI Driven Image

    AI Driven

    Artificial Intelligence is applied to this longitudinal data, aiming to detect and predict respiratory adverse events

  • Better Outcomes Image

    Better Outcomes

    The resulting insights will help clinicians to reduce deaths and hospital admissions from respiratory illness

PneumoWave is under development – performance characteristics have not been established

Respiratory Platform

PneumoWave is an end-to-end, fully integrated platform combining longitudinal patient data, digital biomarkers and machine learning to decode and interpret respiratory changes.

Our initial focus is on reducing deaths from accidental respiratory depression – now the largest cause of death in most developed countries caused by both prescription and illicit medication use.

At the same time, PneumoWave is being developed and evaluated for use in COPD, predicted to become the 3rd leading cause of death worldwide by 2030

PneumoWave Biosensor

PneumoWave Patient Gateway

Our Partners

Commercial, clinical and technology partners.

    • Clinical Trial Partners  Image
    • Clinical Trial Partners  Image
    • Clinical Trial Partners  Image
    • Other Partners Image
    • Other Partners Image
    • Other Partners Image
    • Technology Partners Image
    • Technology Partners Image
    • Technology Partners Image
    • Technology Partners Image

Keep In Touch

Be the first to hear about our latest news